Noam Peleg

1.6k total citations · 1 hit paper
34 papers, 1.1k citations indexed

About

Noam Peleg is a scholar working on Epidemiology, Surgery and Hepatology. According to data from OpenAlex, Noam Peleg has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 17 papers in Surgery and 9 papers in Hepatology. Recurrent topics in Noam Peleg's work include Liver Disease Diagnosis and Treatment (9 papers), Esophageal Cancer Research and Treatment (6 papers) and Inflammatory Bowel Disease (6 papers). Noam Peleg is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Esophageal Cancer Research and Treatment (6 papers) and Inflammatory Bowel Disease (6 papers). Noam Peleg collaborates with scholars based in Israel, United States and Japan. Noam Peleg's co-authors include Amir Shlomai, Susan Bayliss, Giada Sebastiani, Jörn M. Schattenberg, Neeraj Bhala, Stuart McPherson, Hidenori Toyoda, Quentin M. Anstee, Hannes Hagström and Masatoshi Ishigami and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Noam Peleg

29 papers receiving 1.1k citations

Hit Papers

Association Between Fibrosis Stage and Outcomes of Patien... 2020 2026 2022 2024 2020 200 400 600

Peers

Noam Peleg
Brian B. Borg United States
Phirum Nguyen United States
Richard Cross United Kingdom
Sang Jun Suh South Korea
Brian B. Borg United States
Noam Peleg
Citations per year, relative to Noam Peleg Noam Peleg (= 1×) peers Brian B. Borg

Countries citing papers authored by Noam Peleg

Since Specialization
Citations

This map shows the geographic impact of Noam Peleg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noam Peleg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noam Peleg more than expected).

Fields of papers citing papers by Noam Peleg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noam Peleg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noam Peleg. The network helps show where Noam Peleg may publish in the future.

Co-authorship network of co-authors of Noam Peleg

This figure shows the co-authorship network connecting the top 25 collaborators of Noam Peleg. A scholar is included among the top collaborators of Noam Peleg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noam Peleg. Noam Peleg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kirshtein, Boris, et al.. (2025). Frailty Index as a Predictor of Operative Safety and Efficacy in Patients Undergoing Laparoscopic Sleeve Gastrectomy. Obesity Surgery. 35(5). 1603–1610. 1 indexed citations
2.
Peleg, Noam, et al.. (2024). Laparoscopic Gastrojejunostomy Versus Endoscopic Stenting as a Palliative Treatment for Gastric Outlet Obstruction. Journal of Laparoendoscopic & Advanced Surgical Techniques. 34(8). 727–730.
3.
Peleg, Noam, et al.. (2024). Harnessing machine learning in diagnosing complex hoarseness cases. American Journal of Otolaryngology. 46(1). 104533–104533. 2 indexed citations
4.
Pouw, Roos E., Rena Yadlapati, Yonne Peters, et al.. (2024). Neoplastic Progression Risk in Females With Barrett’s Esophagus: A Systematic Review and Meta-Analysis of Individual Patient Data. Clinical Gastroenterology and Hepatology. 23(2). 225–235.e8. 2 indexed citations
5.
Chowers, Yehuda, Jacob E. Ollech, Noam Peleg, et al.. (2024). P331 Photoplethysmography waveform analysis detects inflammatory status in patients with inflammatory bowel disease. Journal of Crohn s and Colitis. 18(Supplement_1). i713–i713.
6.
Peleg, Noam, Yaron Niv, Ram Dickman, et al.. (2024). The Effects of Gluten-free Diet on Body Mass Indexes in Adults with Celiac Disease. Journal of Clinical Gastroenterology. 58(10). 989–997. 1 indexed citations
7.
Hadar, Eran, et al.. (2023). Ondansetron Use During Pregnancy: Birth Defects and Obstetric Outcomes. Clinical Nursing Research. 32(4). 705–711. 1 indexed citations
8.
Peleg, Noam, et al.. (2023). Seattle Protocol Is More Effective in Detection of Dysplasia Compared to Technology-Assisted Targeted Biopsies in Patients with Barrett’s Esophagus. Journal of Clinical Medicine. 12(7). 2544–2544. 6 indexed citations
9.
Sapoznikov, Boris, et al.. (2023). Multi-focal dysplasia is associated with high recurrence rates after successful ablation of dysplastic Barrett's esophagus. Digestive and Liver Disease. 55(12). 1667–1672.
10.
Cheung, Ka Shing, Cheng-Zhi Peng, Lung‐Yi Mak, et al.. (2022). Steatosis, HBV‐related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta‐analysis. Hepatology. 77(5). 1735–1745. 46 indexed citations
11.
Peleg, Noam, Henit Yanai, Rachel Gingold‐Belfer, Iris Dotan, & Irit Avni‐Biron. (2022). Video Capsule Endoscopy after Bariatric Surgery: A Tertiary Referral Center Experience. Digestive Diseases. 41(2). 233–238. 1 indexed citations
12.
Peleg, Noam, Yehuda Ringel, Hemda Schmilovitz‐Weiss, et al.. (2022). Development and validation of a prediction model for histologic progression in patients with nondysplastic Barrett's esophagus. Digestive Endoscopy. 35(6). 718–725. 2 indexed citations
14.
Ollech, Jacob E., Noam Peleg, Jingzhou Wang, et al.. (2020). Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn’s Disease. Clinical Gastroenterology and Hepatology. 19(1). 104–110. 65 indexed citations
15.
Taylor, Rod S, Rebecca J. Taylor, Susan Bayliss, et al.. (2020). Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Gastroenterology. 158(6). 1611–1625.e12. 681 indexed citations breakdown →
16.
Schmilovitz‐Weiss, Hemda, Rachel Gingold‐Belfer, Noam Peleg, et al.. (2020). Use of proton pump inhibitors is associated with lower rates of first‐time ischemic stroke in community‐dwelling elderly. British Journal of Clinical Pharmacology. 87(3). 1187–1193. 3 indexed citations
17.
Peleg, Noam, Assaf Issachar, Michal Cohen‐Naftaly, et al.. (2019). Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load. JHEP Reports. 1(1). 9–16. 52 indexed citations
18.
Peleg, Noam, et al.. (2018). Noninvasive scoring systems predict hepatic and extra-hepatic cancers in patients with nonalcoholic fatty liver disease. PLoS ONE. 13(8). e0202393–e0202393. 37 indexed citations
19.
Peleg, Noam, Michal Cohen‐Naftaly, Marius Braun, et al.. (2018). The Pattern of Elevated Liver Function Tests in Nonalcoholic Fatty Liver Disease Predicts Fibrosis Stage and Metabolic-Associated Comorbidities. Digestive Diseases. 37(1). 69–76. 7 indexed citations
20.
Peleg, Noam, Noam Zevit, Raanan Shamir, Gabriel Chodick, & Itzhak Levy. (2014). Seasonal influenza vaccination rates and reasons for non-vaccination in children with gastrointestinal disorders. Vaccine. 33(1). 182–186. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026